Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2015/404 of 11 March 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb Text with EEA relevance
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 145, captan, the date of β30 September 2017β is replaced by β31Β July 2018β; (2) in the sixth column, expiration of approval, of row 146, folpet, the date of β30 September 2017β is replaced by β31Β July 2018β; (3) in the sixth column, expiration of approval, of row 147, formetanate, the date of β30 September 2017β is replaced by β31 July 2018β; (4) in the sixth column, expiration of approval, of row 148, methiocarb, the date of β30 September 2017β is replaced by β31 July 2018β; (5) in the sixth column, expiration of approval, of row 149, dimethoate, the date of β30 September 2017β is replaced by β31 July 2018β; (6) in the sixth column, expiration of approval, of row 150, dimethomorph, the date of β30 September 2017β is replaced by β31 July 2018β; (7) in the sixth column, expiration of approval, of row 151, glufosinate, the date of β30 September 2017β is replaced by β31 July 2018β; (8) in the sixth column, expiration of approval, of row 152, metribuzin, the date of β30 September 2017β is replaced by β31 July 2018β; (9) in the sixth column, expiration of approval, of row 153, phosmet, the date of β30 September 2017β is replaced by β31 July 2018β; (10) in the sixth column, expiration of approval, of row 154, propamocarb, the date of β30 September 2017β is replaced by β31 July 2018β; (11) in the sixth column, expiration of approval, of row 155, ethoprophos, the date of β30 September 2017β is replaced by β31 July 2018β; (12) in the sixth column, expiration of approval, of row 156, pirimiphos-methyl, the date of β30 September 2017β is replaced by β31 July 2018β; (13) in the sixth column, expiration of approval, of row 157, fipronil, the date of β30 September 2017β is replaced by β31 July 2018β; (14) in the sixth column, expiration of approval, of row 158, beflubutamid, the date of β30 November 2017β is replaced by β31 July 2018β.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.